ArticleMaterials today. Bio2022

A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and

Taiying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.